Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Spyre Therapeutics has the lowest figure of the 52 pharmaceutical companies ranked by revenue, at CZK 0, followed by Praxis Precision Medicines (CZK 0) and Dianthus Therapeutics (CZK 45.2M). Figures as of 18 Nov 2026, 22:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- Lowest
- Spyre TherapeuticsCZK 0
- Median
- CZK 71.1B
- Combined market value
- CZK 112.3T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | CZK 0 | CZK 213.9B | CZK 2,252.24 | 8.15% up | 286% up | ||
| 2 | Praxis Precision MedicinesPRAX · Health Care | CZK 0 | CZK 189.4B | CZK 6,774.70 | 0.04% up | 61% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | CZK 45.2M | CZK 105B | CZK 1,864.21 | 3.45% down | 113% up | ||
| 4 | Roivant SciencesROIV · Health Care | CZK 183.4M | CZK 622.9B | CZK 859.74 | 0.05% up | 90% up | ||
| 5 | Protagonist TherapeuticsPTGX · Health Care | CZK 1B | CZK 184.2B | CZK 2,822.74 | 2.00% up | 46% up | ||
| 6 | CytokineticsCYTK · Health Care | CZK 2B | CZK 158.7B | CZK 1,139.22 | 0.64% down | 20% down | ||
| 7 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 4.2B | CZK 183.2B | CZK 2,642.49 | 2.08% up | 13% up | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | CZK 6B | CZK 132.6B | CZK 6,630.85 | 1.67% up | 43% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | CZK 10.9B | CZK 107.1B | CZK 1,115.24 | 1.68% down | 44% up | ||
| 10 | BridgeBio PharmaBBIO · Health Care | CZK 11.1B | CZK 337.3B | CZK 1,731.69 | 1.58% up | 17% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | CZK 11.6B | CZK 134B | CZK 2,053.12 | 0.59% up | 31% up | ||
| 12 | InsmedINSM · Health Care | CZK 13.5B | CZK 583.4B | CZK 2,659.36 | 1.69% down | 40% down | ||
| 13 | TG TherapeuticsTGTX · Health Care | CZK 13.7B | CZK 221.8B | CZK 1,467.75 | 5.44% up | 107% up | ||
| 14 | Axsome TherapeuticsAXSM · Health Care | CZK 14.2B | CZK 156.5B | CZK 2,974.57 | 1.43% down | 7% down | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 15B | CZK 165.8B | CZK 2,109.95 | 0.06% down | 126% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | CZK 16.9B | CZK 164.7B | CZK 1,504.82 | 3.25% down | 8% down | ||
| 17 | Ascendis PharmaASND · Health Care | CZK 17.7B | CZK 393.6B | CZK 6,000.87 | 0.32% down | 28% up | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 18.4B | CZK 135.3B | CZK 956.97 | 0.28% up | 10% up | ||
| 19 | Ionis PharmaceuticalsIONS · Health Care | CZK 20.9B | CZK 101.3B | CZK 608.01 | 1.59% up | 64% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 21.3B | CZK 205.3B | CZK 8,836.70 | 5.67% down | 24% down | ||
| 21 | Legend BiotechLEGN · Health Care | CZK 22.8B | CZK 70B | CZK 360.72 | 0.87% up | 42% down | ||
| 22 | AlkermesALKS · Health Care | CZK 32.8B | CZK 174.8B | CZK 1,039.99 | 3.08% up | 58% up | ||
| 23 | PTC TherapeuticsPTCT · Health Care | CZK 38.4B | CZK 111.7B | CZK 1,337.00 | 0.22% down | 20% down | ||
| 24 | Royalty PharmaRPRX · Health Care | CZK 52.8B | CZK 876.5B | CZK 1,524.36 | 0.01% down | 78% up | ||
| 25 | Amneal PharmaceuticalsAMRX · Health Care | CZK 67B | CZK 169.2B | CZK 485.70 | 3.60% up | 83% up | ||
| 26 | United TherapeuticsUTHR · Health Care | CZK 70.7B | CZK 545.8B | CZK 12,815.97 | 1.16% down | 23% up | ||
| 27 | BioMarin PharmaceuticalBMRN · Health Care | CZK 71.5B | CZK 264.1B | CZK 1,363.64 | 4.99% up | 11% up | ||
| 28 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 79.3B | CZK 277.2B | CZK 332.53 | 1.28% up | 5% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | CZK 82.4B | CZK 444.2B | CZK 3,316.43 | 4.54% down | 66% down | ||
| 30 | GenmabGMAB · Health Care | CZK 82.6B | CZK 697.6B | CZK 1,131.45 | 1.91% down | 70% up | ||
| 31 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 94.7B | CZK 353B | CZK 5,500.07 | 2.93% up | 37% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | CZK 104.7B | CZK 296.2B | CZK 592.69 | 3.29% up | 20% up | ||
| 33 | BeOne MedicinesONC · Health Care | CZK 118.6B | CZK 1.02T | CZK 8,959.23 | 2.34% down | 17% up | ||
| 34 | GrifolsGRFS · Health Care | CZK 185.3B | CZK 128B | CZK 188.02 | 1.85% down | 1% up | ||
| 35 | ZoetisZTS · Health Care | CZK 210.2B | CZK 771.8B | CZK 1,899.51 | 2.50% up | 29% down | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | CZK 266.4B | CZK 3.02T | CZK 11,908.28 | 0.42% up | 27% up | ||
| 37 | ViatrisVTRS · Health Care | CZK 317.4B | CZK 516.1B | CZK 450.18 | 0.83% down | 96% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | CZK 318.4B | CZK 2.17T | CZK 20,989.16 | 1.28% down | 36% up | ||
| 39 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 383.1B | CZK 1.09T | CZK 937.43 | 0.92% down | 74% up | ||
| 40 | Takeda PharmaceuticalTAK · Health Care | CZK 626.4B | CZK 1.51T | CZK 472.16 | 1.71% down | 54% up | ||
| 41 | GSKGSK · Health Care | CZK 962.5B | CZK 2.16T | CZK 1,078.39 | 1.34% down | 6% up | ||
| 42 | Abbott LaboratoriesABT · Health Care | CZK 984B | CZK 4.02T | CZK 2,319.28 | 0.22% down | 17% down | ||
| 43 | Novo NordiskNVO · Health Care | CZK 1.02T | CZK 3.86T | CZK 875.28 | 3.12% down | 17% down | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | CZK 1.07T | CZK 2.7T | CZK 1,322.13 | 2.92% down | 34% up | ||
| 45 | SanofiSNY · Health Care | CZK 1.07T | CZK 2.51T | CZK 1,045.98 | 0.86% down | 4% down | ||
| 46 | NovartisNVS · Health Care | CZK 1.21T | CZK 6.51T | CZK 3,445.40 | 2.46% down | 25% up | ||
| 47 | AstraZenecaAZN · Health Care | CZK 1.3T | CZK 6.15T | CZK 3,968.17 | 1.93% down | 2% up | ||
| 48 | AbbVieABBV · Health Care | CZK 1.36T | CZK 11.22T | CZK 6,348.94 | 2.33% down | 26% up | ||
| 49 | PfizerPFE · Health Care | CZK 1.39T | CZK 3.55T | CZK 622.88 | 1.44% down | 14% up | ||
| 50 | Merck & CoMRK · Health Care | CZK 1.44T | CZK 7.54T | CZK 3,058.48 | 3.90% down | 51% up | ||
| 51 | Eli LillyLLY · Health Care | CZK 1.45T | CZK 27.34T | CZK 30,694.70 | 2.32% down | 35% up | ||
| 52 | Johnson & JohnsonJNJ · Health Care | CZK 2.09T | CZK 14.57T | CZK 6,053.48 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.1983 CZK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest revenue?
Spyre Therapeutics (CZK 0), Praxis Precision Medicines (CZK 0) and Dianthus Therapeutics (CZK 45.2M) have the lowest revenue of the 52 pharmaceutical companies ranked here as of 18 Nov 2026, 22:22 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of CZK 112.3T as of 18 Nov 2026, 22:22 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.